U.S. Fertility Diagnostic Market Size, Share & Trends Analysis Report By Procedure Type (X-ray-Based Tubal Patency Testing, Structural & Morphologic Imaging), By Technology Type, By Clinical Setting, By Region, And Segment Forecasts, 2026 - 2033
The U.S. fertility diagnostic market size was valued at USD 1.07 billion in 2025 and is projected to reach USD 1.92 billion by 2033, growing at a CAGR of 7.6% from 2026 to 2033. The rise in infertility and high rate of identifiable causes are key factors driving the U.S. market for fertility diagnostics.
In addition, the increasing emphasis on comprehensive diagnostic evaluations is supporting the continued growth and technological advancement of fertility diagnostic solutions. The section below outlines key market factors such as research and development and trends shaping the fertility diagnostic market. It reflects technological advancements, the impact of demographics, and other factors that are strengthening diagnostic capabilities, improving early infertility detection, and expanding access to advanced fertility testing solutions across the U.S.
U.S. Fertility Diagnostic Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. fertility diagnostic market report based on procedure type, technology, clinical setting, and region.
In addition, the increasing emphasis on comprehensive diagnostic evaluations is supporting the continued growth and technological advancement of fertility diagnostic solutions. The section below outlines key market factors such as research and development and trends shaping the fertility diagnostic market. It reflects technological advancements, the impact of demographics, and other factors that are strengthening diagnostic capabilities, improving early infertility detection, and expanding access to advanced fertility testing solutions across the U.S.
U.S. Fertility Diagnostic Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. fertility diagnostic market report based on procedure type, technology, clinical setting, and region.
- Procedure Type Outlook (Revenue, USD Billion, 2021 - 2033)
- X-ray-Based Tubal Patency Testing
- Ultrasound-Based Tubal Patency Testing
- HyCoSy (Hysterosalpingo-Contrast Sonography)
- HyFoSy (Hysterosalpingo-Foam Sonography)
- Others
- Proprietary Controlled Contrast Systems Subdermal Implants
- Structural & Morphologic Imaging
- Others
- Technology Outlook (Revenue, USD Billion, 2021 - 2033)
- X-Ray-Based Technologies
- Ultrasound-Based Technologies
- Proprietary Diagnostic Devices
- Clinical Setting Outlook (Revenue, USD Billion, 2021 - 2033)
- Fertility & Reproductive Medicine Clinics
- Gynecology / Women’s Health Practices
- Radiology & Imaging Centers
- Hospital Outpatient Departments
- Others
- Region Outlook (Revenue, USD Million, 2021 - 2033)
- West
- Southwest
- Southeast
- Midwest
- Northeast
CHAPTER 1 REPORT SCOPE & RESEARCH METHODOLOGY
1.1 Market Segmentation
1.1.1 Segment Definition
1.1.1.1 Procedure Type
1.1.1.2 Technology type
1.1.1.3 Clinical setting
1.2 Estimates and Forecast Timeline
1.3 Research Methodology
1.3.1 Information Procurement
1.3.2 Purchased Database
1.3.3 GVR’s Internal Database
1.3.4 Secondary Sources
1.3.5 Primary Research
1.3.6 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Three Pillars of Market Estimation
1.6.1.1 Secondary market research
1.6.1.2 Primary market intelligence
1.6.1.2.1 In-depth interviews (IDIs)
1.6.1.2.2 Online survey program
1.6.2 Market Modeling & Forecasting
1.6.2.1 Model 1: Procedure Type volume analysis
1.6.2.2 Model 2: Technology adoption allocation
1.6.2.3 Model 3: Device utilization modeling
1.6.2.4 Model 4: Revenue estimation (Volume ? Price)
1.6.2.5 Top-down validation (Manufacturer revenue benchmarking)
1.6.2.6 CAGR/forecasting calculations & assumptions
1.6.2.6.1 Key forecasting drivers and weights
1.6.2.6.2 Scenario framework (2026 - 2033)
1.6.2.6.3 Factor-based impact assessment
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Research Objectives
1.9.1 Objective -
1.9.2 Objective -
1.9.3 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Procedure Type and Technology Type Snapshot
2.3 Clinical Setting Snapshot
2.4 Competitive Landscape Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Delayed parenthood and changing demographics
3.1.1.1.1 Case study published by the U.S. Census Bureau in January 2026: Reducing U.S. population growth and its implications for the fertility diagnostic market
3.1.1.2 Rising prevalence of infertility
3.1.1.3 Growth of assisted reproductive technologies (ART)
3.1.1.3.1 Case study published in Gray Local Media Station in February 2026: Expansion of IVF clinics to meet rising ART demand in the U.S.
3.1.2 Market Restraint Analysis
3.1.2.1 High costs and limited reimbursement
3.1.2.2 Technological and data integration challenges
3.1.3 Market Opportunity Analysis
3.1.3.1 At home & point of care diagnostic solutions
3.1.3.2 Expansion of male fertility diagnostics
3.1.4 Market Challenge Analysis
3.1.4.1 Regulatory complexity & approval delays
3.2 Fertility Diagnostic Products: Regulatory Framework and Reimbursement Scenario
3.3 Technology Landscape
3.3.1 Case study published by the National Library of Medicine in March 2024: accuracy of Hystero-Salpingo-Foam Sonography (Hyfosy) for tubal patency testing
3.4 Industry Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 Pestle Analysis
CHAPTER 4 U.S. INFERTILITY MARKET ANALYSIS
4.1 U.S. Infertility Market, 2021 - 2033 (USD Billion)
4.2 Prevalence/Incidence of Infertility in the U.S., by Gender, 2025
4.3 Impact of Infertility Prevalence/Incidence on Demand for Fertility Diagnostics
4.3.1 Case study published by National Library of Medicine: impact of infertility prevalence on demand for fertility diagnostics
4.3.2 Case study published by Raveco Medical in September 2025: importance of early infertility evaluation and its impact on fertility diagnostics demand
CHAPTER 5 U.S. FERTILITY DIAGNOSTIC MARKET: TAM, SAM, AND SOM ANALYSIS
5.1 Total Addressable Market (TAM) Analysis, 2021 to 2033 (USD Billion)
5.2 Serviceable Addressable Market (SAM) Analysis, 2021 to 2033 (USD Billion)
5.3 Serviceable Obtainable Market (SOM) Analysis, 2021 to 2033 (USD Billion)
CHAPTER 6 U.S. FERTILITY DIAGNOSTIC MARKET: PROCEDURE TYPE ESTIMATES & TREND ANALYSIS
6.1 U.S. Fertility Diagnostic Market: Procedure Type Segment Dashboard
6.2 Procedure Type Movement & Market Share Analysis, 2025 & 2033
6.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Procedure Type, 2021 - 2033 (USD Million)
6.3.1 X-Ray-Based Tubal Patency Testing
6.3.1.1 X-ray-based tubal patency testing market, 2021 - 2033 (USD Million)
6.3.1.2 X-ray-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.2 Ultrasound-Based Tubal Patency Testing
6.3.2.1 Ultrasound-based tubal patency testing market, 2021 - 2033 (USD Million)
6.3.2.2 Ultrasound-based tubal Patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.2.3 HyCoSy (hysterosalpingo-contrast sonography)
6.3.2.3.1 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (USD Million)
6.3.2.3.2 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (Annual Procedure Type Estimates in Thousands)
6.3.2.4 HyFoSy (hysterosalpingo-foam sonography)
6.3.2.4.1 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (USD Million)
6.3.2.4.2 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.2.5 Others
6.3.2.5.1 Others market, 2021 - 2033 (USD Million)
6.3.2.5.2 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.3 Proprietary Controlled Contrast Systems
6.3.3.1 Proprietary controlled contrast systems market, 2021 - 2033 (USD Million)
6.3.3.2 Proprietary controlled contrast systems market, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.4 Structural & Morphologic Imaging
6.3.4.1 Structural & morphologic imaging market, 2021 - 2033 (USD Million)
6.3.4.2 Structural & morphologic imaging market, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.5 Others
6.3.5.1 Others market, 2021 - 2033 (USD Million)
6.3.5.2 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)
CHAPTER 7 U.S. FERTILITY DIAGNOSTIC MARKET: TECHNOLOGY TYPE ESTIMATES & TREND ANALYSIS
7.1 U.S. Fertility Diagnostic Market: Technology Type Segment Dashboard
7.2 Technology Type Movement & Market Share Analysis, 2025 & 2033
7.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Technology Type, 2021 - 2033 (USD Million)
7.3.1 X-Ray-Based Technologies
7.3.1.1 X-ray-based technologies market, 2021 - 2033 (USD Million)
7.3.2 Ultrasound-Based Technologies
7.3.2.1 Ultrasound-based technologies market, 2021 - 2033 (USD Million)
7.3.3 Proprietary Diagnostic Devices
7.3.3.1 Proprietary diagnostic devices market, 2021 - 2033 (USD Million)
CHAPTER 8 U.S. FERTILITY DIAGNOSTIC MARKET: CLINICAL SETTING ESTIMATES & TREND ANALYSIS
8.1 U.S. Fertility Diagnostic Market: Clinical Setting Segment Dashboard
8.2 Clinical Setting Movement & Market Share Analysis, 2025 & 2033
8.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Clinical Setting, 2021 - 2033 (USD Million)
8.3.1 Fertility & Reproductive Medicine Clinics
8.3.1.1 Fertility & reproductive medicine clinics market, 2021 - 2033 (USD Million)
8.3.2 Gynecology / Women’s Health Practices
8.3.2.1 Gynecology / women’s health practices market, 2021 - 2033 (USD Million)
8.3.3 Radiology & Imaging Centers
8.3.3.1 Radiology & imaging centers market, 2021 - 2033 (USD Million)
8.3.4 Hospital Outpatient Departments
8.3.4.1 Hospital outpatient departments market, 2021 - 2033 (USD Million)
8.3.5 others
8.3.5.1 Others market, 2021 - 2033 (USD Million)
CHAPTER 9. U.S. FERTILITY DIAGNOSTIC MARKET: REGION ESTIMATES & TREND ANALYSIS
9.1 U.S. Fertility diagnostic Market: Region Movement Analysis
9.2. U.S. Fertility Diagnostic Market: Region Segment Dashboard
9.3. Region Movement & Market Share Analysis, 2025 & 2033
9.4. U.S. Fertility Diagnostic Market Estimates & Forecast, by Region
9.5. West
9.5.1. West Market, 2021 - 2033 (USD Million)
9.6. Southeast
9.6.1. Southeast Market, 2021 - 2033 (USD Million)
9.7. Southwest
9.7.1. Southwest Market, 2021 - 2033 (USD Million)
9.8. Midwest
9.8.1. Midwest Market, 2021 - 2033 (USD Million)
9.9. Northeast
9.9.1. Northeast Market, 2021 - 2033 (USD Million)
CHAPTER 10 U.S. FERTILITY DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE
10.1 Participants’ Overview
10.2 Financial Performance
10.3 Product Benchmarking
10.3.1 Gedeon Richter
10.3.1.1. Overview
10.3.1.2. Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.3.1 Sonography
10.3.2 Femvue (Femasys Inc.)
10.3.2.1. Overview
10.3.2.2. Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.3.1 Tube testing
10.3.3 Thomas Medical (MedGyn)
10.3.3.1. Overview
10.3.3.2. Financial Performance
10.3.3.3 Product Benchmarking
10.3.3.3.1 Infertility care
10.3.4 Koninklijke Philips N.V.
10.3.4.1. Overview
10.3.4.2. Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.3.1 Gynecology ultrasound
10.3.5 Ge Healthcare
10.3.5.1. Overview
10.3.5.2. Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.3.1 Ultrasound
10.3.6 Samsung Healthcare
10.3.6.1. Overview
10.3.6.2. Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.3.1 Reproductive endocrinology and infertility
10.3.7 Cooper Surgical, Inc.
10.3.7.1. Overview
10.3.7.2. Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.3.1. Andrology testing
10.3.7.3.2 Embryo assessment diagnostics
10.3.7.3.3 Hormone & biochemical fertility testing
10.3.7.3.4 Milex support pessaries
10.3.8 Mindray Ds Usa, Inc.
10.3.8.1. Overview
10.3.8.2. Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.3.1 Ultrasound solutions
10.3.8.3.2 In vitro diagnostics
10.3.9 Vio Healthtech Inc
10.3.9.1 OvuSense tracker
10.3.9.1. Overview
10.3.9.2. Financial Performance
10.3.9.3 Product Benchmarking
10.3.9.3.1 Ovusensor tracker.
10.3.10 Fujifilm Sonosite, Inc.
10.3.10.1. Overview
10.3.10.2. Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.3.1 Portable ultrasound machines
10.3.11 Olympus
10.3.11.1. Overview
10.3.11.2. Financial Performance
10.3.11.3 Product Benchmarking
10.3.11.3.1 Microscopes & others
10.3.12 Canon Medical Systems
10.3.12.1. Overview
10.3.12.2. Financial Performance
10.3.12.3 Product Benchmarking
10.3.12.3.1 Ultrasound
10.3.13 Stryker
10.3.13.1. Overview
10.3.13.2. Financial Performance
10.3.13.3 Product Benchmarking
10.3.13.4 Imaging systems
10.4 Participant Categorization
10.5 Company Market Position Analysis, 2025
10.6 Company Market Share Analysis, by Procedure Type, 2025
10.7 Strategy Mapping
10.7.1 New Product Launch
10.7.2 Mergers & Acquisitions
10.7.3 Partnership & Collaboration
10.7.4 Market Expansion
10.7.5 Product Approvals
1.1 Market Segmentation
1.1.1 Segment Definition
1.1.1.1 Procedure Type
1.1.1.2 Technology type
1.1.1.3 Clinical setting
1.2 Estimates and Forecast Timeline
1.3 Research Methodology
1.3.1 Information Procurement
1.3.2 Purchased Database
1.3.3 GVR’s Internal Database
1.3.4 Secondary Sources
1.3.5 Primary Research
1.3.6 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Three Pillars of Market Estimation
1.6.1.1 Secondary market research
1.6.1.2 Primary market intelligence
1.6.1.2.1 In-depth interviews (IDIs)
1.6.1.2.2 Online survey program
1.6.2 Market Modeling & Forecasting
1.6.2.1 Model 1: Procedure Type volume analysis
1.6.2.2 Model 2: Technology adoption allocation
1.6.2.3 Model 3: Device utilization modeling
1.6.2.4 Model 4: Revenue estimation (Volume ? Price)
1.6.2.5 Top-down validation (Manufacturer revenue benchmarking)
1.6.2.6 CAGR/forecasting calculations & assumptions
1.6.2.6.1 Key forecasting drivers and weights
1.6.2.6.2 Scenario framework (2026 - 2033)
1.6.2.6.3 Factor-based impact assessment
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Research Objectives
1.9.1 Objective -
1.9.2 Objective -
1.9.3 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Procedure Type and Technology Type Snapshot
2.3 Clinical Setting Snapshot
2.4 Competitive Landscape Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Delayed parenthood and changing demographics
3.1.1.1.1 Case study published by the U.S. Census Bureau in January 2026: Reducing U.S. population growth and its implications for the fertility diagnostic market
3.1.1.2 Rising prevalence of infertility
3.1.1.3 Growth of assisted reproductive technologies (ART)
3.1.1.3.1 Case study published in Gray Local Media Station in February 2026: Expansion of IVF clinics to meet rising ART demand in the U.S.
3.1.2 Market Restraint Analysis
3.1.2.1 High costs and limited reimbursement
3.1.2.2 Technological and data integration challenges
3.1.3 Market Opportunity Analysis
3.1.3.1 At home & point of care diagnostic solutions
3.1.3.2 Expansion of male fertility diagnostics
3.1.4 Market Challenge Analysis
3.1.4.1 Regulatory complexity & approval delays
3.2 Fertility Diagnostic Products: Regulatory Framework and Reimbursement Scenario
3.3 Technology Landscape
3.3.1 Case study published by the National Library of Medicine in March 2024: accuracy of Hystero-Salpingo-Foam Sonography (Hyfosy) for tubal patency testing
3.4 Industry Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 Pestle Analysis
CHAPTER 4 U.S. INFERTILITY MARKET ANALYSIS
4.1 U.S. Infertility Market, 2021 - 2033 (USD Billion)
4.2 Prevalence/Incidence of Infertility in the U.S., by Gender, 2025
4.3 Impact of Infertility Prevalence/Incidence on Demand for Fertility Diagnostics
4.3.1 Case study published by National Library of Medicine: impact of infertility prevalence on demand for fertility diagnostics
4.3.2 Case study published by Raveco Medical in September 2025: importance of early infertility evaluation and its impact on fertility diagnostics demand
CHAPTER 5 U.S. FERTILITY DIAGNOSTIC MARKET: TAM, SAM, AND SOM ANALYSIS
5.1 Total Addressable Market (TAM) Analysis, 2021 to 2033 (USD Billion)
5.2 Serviceable Addressable Market (SAM) Analysis, 2021 to 2033 (USD Billion)
5.3 Serviceable Obtainable Market (SOM) Analysis, 2021 to 2033 (USD Billion)
CHAPTER 6 U.S. FERTILITY DIAGNOSTIC MARKET: PROCEDURE TYPE ESTIMATES & TREND ANALYSIS
6.1 U.S. Fertility Diagnostic Market: Procedure Type Segment Dashboard
6.2 Procedure Type Movement & Market Share Analysis, 2025 & 2033
6.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Procedure Type, 2021 - 2033 (USD Million)
6.3.1 X-Ray-Based Tubal Patency Testing
6.3.1.1 X-ray-based tubal patency testing market, 2021 - 2033 (USD Million)
6.3.1.2 X-ray-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.2 Ultrasound-Based Tubal Patency Testing
6.3.2.1 Ultrasound-based tubal patency testing market, 2021 - 2033 (USD Million)
6.3.2.2 Ultrasound-based tubal Patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.2.3 HyCoSy (hysterosalpingo-contrast sonography)
6.3.2.3.1 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (USD Million)
6.3.2.3.2 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (Annual Procedure Type Estimates in Thousands)
6.3.2.4 HyFoSy (hysterosalpingo-foam sonography)
6.3.2.4.1 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (USD Million)
6.3.2.4.2 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.2.5 Others
6.3.2.5.1 Others market, 2021 - 2033 (USD Million)
6.3.2.5.2 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.3 Proprietary Controlled Contrast Systems
6.3.3.1 Proprietary controlled contrast systems market, 2021 - 2033 (USD Million)
6.3.3.2 Proprietary controlled contrast systems market, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.4 Structural & Morphologic Imaging
6.3.4.1 Structural & morphologic imaging market, 2021 - 2033 (USD Million)
6.3.4.2 Structural & morphologic imaging market, 2021 - 2033 (Annual procedure type estimates in thousands)
6.3.5 Others
6.3.5.1 Others market, 2021 - 2033 (USD Million)
6.3.5.2 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)
CHAPTER 7 U.S. FERTILITY DIAGNOSTIC MARKET: TECHNOLOGY TYPE ESTIMATES & TREND ANALYSIS
7.1 U.S. Fertility Diagnostic Market: Technology Type Segment Dashboard
7.2 Technology Type Movement & Market Share Analysis, 2025 & 2033
7.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Technology Type, 2021 - 2033 (USD Million)
7.3.1 X-Ray-Based Technologies
7.3.1.1 X-ray-based technologies market, 2021 - 2033 (USD Million)
7.3.2 Ultrasound-Based Technologies
7.3.2.1 Ultrasound-based technologies market, 2021 - 2033 (USD Million)
7.3.3 Proprietary Diagnostic Devices
7.3.3.1 Proprietary diagnostic devices market, 2021 - 2033 (USD Million)
CHAPTER 8 U.S. FERTILITY DIAGNOSTIC MARKET: CLINICAL SETTING ESTIMATES & TREND ANALYSIS
8.1 U.S. Fertility Diagnostic Market: Clinical Setting Segment Dashboard
8.2 Clinical Setting Movement & Market Share Analysis, 2025 & 2033
8.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Clinical Setting, 2021 - 2033 (USD Million)
8.3.1 Fertility & Reproductive Medicine Clinics
8.3.1.1 Fertility & reproductive medicine clinics market, 2021 - 2033 (USD Million)
8.3.2 Gynecology / Women’s Health Practices
8.3.2.1 Gynecology / women’s health practices market, 2021 - 2033 (USD Million)
8.3.3 Radiology & Imaging Centers
8.3.3.1 Radiology & imaging centers market, 2021 - 2033 (USD Million)
8.3.4 Hospital Outpatient Departments
8.3.4.1 Hospital outpatient departments market, 2021 - 2033 (USD Million)
8.3.5 others
8.3.5.1 Others market, 2021 - 2033 (USD Million)
CHAPTER 9. U.S. FERTILITY DIAGNOSTIC MARKET: REGION ESTIMATES & TREND ANALYSIS
9.1 U.S. Fertility diagnostic Market: Region Movement Analysis
9.2. U.S. Fertility Diagnostic Market: Region Segment Dashboard
9.3. Region Movement & Market Share Analysis, 2025 & 2033
9.4. U.S. Fertility Diagnostic Market Estimates & Forecast, by Region
9.5. West
9.5.1. West Market, 2021 - 2033 (USD Million)
9.6. Southeast
9.6.1. Southeast Market, 2021 - 2033 (USD Million)
9.7. Southwest
9.7.1. Southwest Market, 2021 - 2033 (USD Million)
9.8. Midwest
9.8.1. Midwest Market, 2021 - 2033 (USD Million)
9.9. Northeast
9.9.1. Northeast Market, 2021 - 2033 (USD Million)
CHAPTER 10 U.S. FERTILITY DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE
10.1 Participants’ Overview
10.2 Financial Performance
10.3 Product Benchmarking
10.3.1 Gedeon Richter
10.3.1.1. Overview
10.3.1.2. Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.3.1 Sonography
10.3.2 Femvue (Femasys Inc.)
10.3.2.1. Overview
10.3.2.2. Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.3.1 Tube testing
10.3.3 Thomas Medical (MedGyn)
10.3.3.1. Overview
10.3.3.2. Financial Performance
10.3.3.3 Product Benchmarking
10.3.3.3.1 Infertility care
10.3.4 Koninklijke Philips N.V.
10.3.4.1. Overview
10.3.4.2. Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.3.1 Gynecology ultrasound
10.3.5 Ge Healthcare
10.3.5.1. Overview
10.3.5.2. Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.3.1 Ultrasound
10.3.6 Samsung Healthcare
10.3.6.1. Overview
10.3.6.2. Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.3.1 Reproductive endocrinology and infertility
10.3.7 Cooper Surgical, Inc.
10.3.7.1. Overview
10.3.7.2. Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.3.1. Andrology testing
10.3.7.3.2 Embryo assessment diagnostics
10.3.7.3.3 Hormone & biochemical fertility testing
10.3.7.3.4 Milex support pessaries
10.3.8 Mindray Ds Usa, Inc.
10.3.8.1. Overview
10.3.8.2. Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.3.1 Ultrasound solutions
10.3.8.3.2 In vitro diagnostics
10.3.9 Vio Healthtech Inc
10.3.9.1 OvuSense tracker
10.3.9.1. Overview
10.3.9.2. Financial Performance
10.3.9.3 Product Benchmarking
10.3.9.3.1 Ovusensor tracker.
10.3.10 Fujifilm Sonosite, Inc.
10.3.10.1. Overview
10.3.10.2. Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.3.1 Portable ultrasound machines
10.3.11 Olympus
10.3.11.1. Overview
10.3.11.2. Financial Performance
10.3.11.3 Product Benchmarking
10.3.11.3.1 Microscopes & others
10.3.12 Canon Medical Systems
10.3.12.1. Overview
10.3.12.2. Financial Performance
10.3.12.3 Product Benchmarking
10.3.12.3.1 Ultrasound
10.3.13 Stryker
10.3.13.1. Overview
10.3.13.2. Financial Performance
10.3.13.3 Product Benchmarking
10.3.13.4 Imaging systems
10.4 Participant Categorization
10.5 Company Market Position Analysis, 2025
10.6 Company Market Share Analysis, by Procedure Type, 2025
10.7 Strategy Mapping
10.7.1 New Product Launch
10.7.2 Mergers & Acquisitions
10.7.3 Partnership & Collaboration
10.7.4 Market Expansion
10.7.5 Product Approvals
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Percentage of first births, by age of mother: U.S., 2018 - 2023
Table 4 Annual incidence rates of female infertility diagnoses by age group, active component service women, US armed forces, 2019 - 2023
Table 5 Common tests for evaluating ovarian reserve and associated costs:
Table 6 Cost comparison - HyFoSy vs HSG
Table 7 Notable fertility diagnostic products available in or relevant to the US market
Table 8 U.S. infertility market, 2021 - 2033 (USD Billion) Total addressable market (TAM) analysis, 2021 to 2033 (USD Billion)
Table 9 Serviceable addressable market (SAM) analysis, 2021 to 2033 (USD Billion)
Table 10 Serviceable obtainable market (SOM) analysis, 2021 to 2033 (USD Billion)
Table 11 U.S. fertility diagnostic market, by procedure type 2021 - 2033 (USD Million)
Table 12 U.S. fertility diagnostic market, by technology type, 2021 - 2033 (USD Million)
Table 13 U.S. fertility diagnostic market, by clinical setting, 2021 - 2033 (USD Million)
Table 14 U.S. fertility diagnostic market revenue estimates and forecast, by region, 2021 - 2033 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Percentage of first births, by age of mother: U.S., 2018 - 2023
Table 4 Annual incidence rates of female infertility diagnoses by age group, active component service women, US armed forces, 2019 - 2023
Table 5 Common tests for evaluating ovarian reserve and associated costs:
Table 6 Cost comparison - HyFoSy vs HSG
Table 7 Notable fertility diagnostic products available in or relevant to the US market
Table 8 U.S. infertility market, 2021 - 2033 (USD Billion) Total addressable market (TAM) analysis, 2021 to 2033 (USD Billion)
Table 9 Serviceable addressable market (SAM) analysis, 2021 to 2033 (USD Billion)
Table 10 Serviceable obtainable market (SOM) analysis, 2021 to 2033 (USD Billion)
Table 11 U.S. fertility diagnostic market, by procedure type 2021 - 2033 (USD Million)
Table 12 U.S. fertility diagnostic market, by technology type, 2021 - 2033 (USD Million)
Table 13 U.S. fertility diagnostic market, by clinical setting, 2021 - 2033 (USD Million)
Table 14 U.S. fertility diagnostic market revenue estimates and forecast, by region, 2021 - 2033 (USD Million)
LIST OF FIGURES
Fig. 1 U.S. fertility diagnostic market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 U.S. fertility diagnostic market snapshot
Fig. 9 U.S. fertility diagnostic market: Procedure type, and technology type snapshot
Fig. 10 U.S. fertility diagnostic market: Clinical setting snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 U.S. fertility diagnostic market dynamics
Fig. 13 Market driver relevance analysis (Current & future impact)
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 U.S. fertility diagnostic market: Porter’s five forces analysis
Fig. 16 U.S. fertility diagnostic market: PESTLE analysis
Fig. 17 Prevalence/incidence of infertility in the US, by gender, 2025 %
Fig. 18 U.S. fertility diagnostic market: Procedure Type segment dashboard
Fig. 19 U.S. fertility diagnostic market: Procedure Type market share analysis, 2025 & 2033
Fig. 20 X-ray-based tubal patency testing market, 2021 - 2033 (USD Million)
Fig. 21 X-ray-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 22 Ultrasound-based tubal patency testing market, 2021 - 2033 (USD Million)
Fig. 23 Ultrasound-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 24 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (USD Million)
Fig. 25 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 26 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (USD Million)
Fig. 27 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 28 Other markets, 2021 - 2033 (USD Million)
Fig. 29 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 30 Proprietary controlled contrast systems market, 2021 - 2033 (USD Million)
Fig. 31 Proprietary controlled contrast systems market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 32 Structural & morphologic imaging market, 2021 - 2033 (USD Million)
Fig. 33 Structural & morphologic imaging market, 2021 - 2033 (Annual procedure type estimates in thousand)
Fig. 34 Others market, 2021 - 2033 (USD Million)
Fig. 35 Others market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 36 U.S. fertility diagnostic market: Technology type segment dashboard
Fig. 37 U.S. fertility diagnostic market: Technology type market share analysis, 2025 & 2033
Fig. 38 X-ray-based technologies market, 2021 - 2033 (USD Million)
Fig. 39 Ultrasound-based technologies market, 2021 - 2033 (USD Million)
Fig. 40 Proprietary diagnostic devices market, 2021 - 2033 (USD Million)
Fig. 41 U.S. fertility diagnostic market: Clinical setting segment dashboard
Fig. 42 U.S. fertility diagnostic market: Clinical setting market share analysis, 2025 & 2033
Fig. 43 Fertility & reproductive medicine clinics market, 2021 - 2033 (USD Million)
Fig. 44 Gynecology / women’s health practices market, 2021 - 2033 (USD Million)
Fig. 45 Radiology & imaging centers market, 2021 - 2033 (USD Million)
Fig. 46 Hospital outpatient departments market, 2021 - 2033 (USD Million)
Fig. 47 Others market, 2021 - 2033 (USD Million)
Fig. 48 USfertility diagnostic market: Region movement analysis
Fig. 49 U.S. fertility diagnostic market: Region segment dashboard
Fig. 50 Northeast market, 2021 - 2033 (USD Million)
Fig. 51 Southeast market, 2021 - 2033 (USD Million)
Fig. 52 Southwest market, 2021 - 2033 (USD Million)
Fig. 53 Midwest market, 2021 - 2033 (USD Million)
Fig. 54 West market, 2021 - 2033 (USD Million)
Fig. 55 Company categorization
Fig. 56 Company market position analysis, 2025
Fig. 57 Strategy mapping
Fig. 1 U.S. fertility diagnostic market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 U.S. fertility diagnostic market snapshot
Fig. 9 U.S. fertility diagnostic market: Procedure type, and technology type snapshot
Fig. 10 U.S. fertility diagnostic market: Clinical setting snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 U.S. fertility diagnostic market dynamics
Fig. 13 Market driver relevance analysis (Current & future impact)
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 U.S. fertility diagnostic market: Porter’s five forces analysis
Fig. 16 U.S. fertility diagnostic market: PESTLE analysis
Fig. 17 Prevalence/incidence of infertility in the US, by gender, 2025 %
Fig. 18 U.S. fertility diagnostic market: Procedure Type segment dashboard
Fig. 19 U.S. fertility diagnostic market: Procedure Type market share analysis, 2025 & 2033
Fig. 20 X-ray-based tubal patency testing market, 2021 - 2033 (USD Million)
Fig. 21 X-ray-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 22 Ultrasound-based tubal patency testing market, 2021 - 2033 (USD Million)
Fig. 23 Ultrasound-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 24 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (USD Million)
Fig. 25 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 26 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (USD Million)
Fig. 27 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 28 Other markets, 2021 - 2033 (USD Million)
Fig. 29 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 30 Proprietary controlled contrast systems market, 2021 - 2033 (USD Million)
Fig. 31 Proprietary controlled contrast systems market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 32 Structural & morphologic imaging market, 2021 - 2033 (USD Million)
Fig. 33 Structural & morphologic imaging market, 2021 - 2033 (Annual procedure type estimates in thousand)
Fig. 34 Others market, 2021 - 2033 (USD Million)
Fig. 35 Others market, 2021 - 2033 (Annual procedure type estimates in thousands)
Fig. 36 U.S. fertility diagnostic market: Technology type segment dashboard
Fig. 37 U.S. fertility diagnostic market: Technology type market share analysis, 2025 & 2033
Fig. 38 X-ray-based technologies market, 2021 - 2033 (USD Million)
Fig. 39 Ultrasound-based technologies market, 2021 - 2033 (USD Million)
Fig. 40 Proprietary diagnostic devices market, 2021 - 2033 (USD Million)
Fig. 41 U.S. fertility diagnostic market: Clinical setting segment dashboard
Fig. 42 U.S. fertility diagnostic market: Clinical setting market share analysis, 2025 & 2033
Fig. 43 Fertility & reproductive medicine clinics market, 2021 - 2033 (USD Million)
Fig. 44 Gynecology / women’s health practices market, 2021 - 2033 (USD Million)
Fig. 45 Radiology & imaging centers market, 2021 - 2033 (USD Million)
Fig. 46 Hospital outpatient departments market, 2021 - 2033 (USD Million)
Fig. 47 Others market, 2021 - 2033 (USD Million)
Fig. 48 USfertility diagnostic market: Region movement analysis
Fig. 49 U.S. fertility diagnostic market: Region segment dashboard
Fig. 50 Northeast market, 2021 - 2033 (USD Million)
Fig. 51 Southeast market, 2021 - 2033 (USD Million)
Fig. 52 Southwest market, 2021 - 2033 (USD Million)
Fig. 53 Midwest market, 2021 - 2033 (USD Million)
Fig. 54 West market, 2021 - 2033 (USD Million)
Fig. 55 Company categorization
Fig. 56 Company market position analysis, 2025
Fig. 57 Strategy mapping
